BC
BLUE

Brinker Capital’s bluebird bio BLUE Stock Holding History

Brinker Capital’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$708K Sell
896
-13
-1% -$9.8K 0.02% 608
2020
Q1 		$541K Buy
909
+497
+121% +$484K 0.02% 616
2019
Q4 		$468K Sell
412
-254
-38% -$276K 0.01% 731
2019
Q3 		$792K Buy
666
+96
+17% +$147K 0.03% 561
2019
Q2 		$940K Buy
570
+56
+11% +$96.9K 0.03% 493
2019
Q1 		$1.05M Buy
514
+100
+24% +$176K 0.04% 441
2018
Q4 		$532K Buy
+414
New +$635K 0.02% 581

Other funds holding BLUE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Brinker Capital's BLUE Position: Q2 2020 in Review

Brinker Capital reduced its bluebird bio (BLUE) stake by 1.4% in Q2 2020, selling an estimated $9.8K and leaving 896 shares worth $708K. The position accounts for 0.02% of the portfolio, ranked #608.

Brinker Capital first reported a position in BLUE in Q4 2018 and has held it in 7 quarters since. The position peaked at $1.05M in Q1 2019. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.

  • Brinker Capital held 896 shares of bluebird bio worth $708K as of Q2 2020.
  • Brinker Capital sold 13 bluebird bio shares in Q2 2020, an estimated $9.8K.
  • bluebird bio made up 0.02% of Brinker Capital's portfolio in Q2 2020, its #608 holding.
  • Brinker Capital first reported a position in bluebird bio in Q4 2018 and has held it in 7 quarters since.
  • Brinker Capital's bluebird bio position peaked at $1.05M in Q1 2019.
  • 278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.